When someone mentions India, what comes to your mind first? Rich curry, green trains overloaded with passengers, gorgeous and exotic women with headscarves and jubilant Bollywood movies may be most peoples’ answer. In actual fact, India can also be seen as a medical market of 1.3 billion people. Firstly, India is the world’s second most populous country with a population of 1.3 billion and a giant demand for pharmaceuticals and medical devices. According to a report by credit rating agency CRISIL, the population of India is estimated to reach 1.4 billion by the year 2026 with half the population being over 30 years old, increasing from the present 40% to an estimated 50%. This means that India will have a greater demand for pharmaceuticals and medical devices and more sufficient medical services for the aging population than ever before. The number of deaths in India in 2012 was estimated to be 9.8 million, of which 77% died from illness and health problems.The ...
Offering a quotation to a client is not always as simple as it sounds and may take some time to master. How can we swiftly attract clients and ensure effective communication with potential customers in a short amount of time?
The 17th Indian Premier B2B Medical Equipment Show (Medicall 2017) will be held in Chennai, the fourth largest city in India, from July 28 to July 30, 2017. As the leading global pharmaceuticals and medical devices B2B online platform, Ddu is going to focus on showcasing their online-to-offline promotional exhibition method along with the products of high priority members in India.
The Shanghai International Clinical Examination Equipment and Products Exhibition 2017 (CEEP) was held at the Shanghai World Expo Exhibition and Convention Center from July 13 to July 15, 2017. Ddu, the leading global pharmaceuticals and medical devices B2B online platform, attended Shanghai CEEP with products of high priority members and publically presented the Ddu app, receiving high praise.
The 5th International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) was grandly held in Myanmar's capital, Yangon from July 5 - 7, 2017. As the leading global pharmaceuticals and medical devices B2B online platform, Drugdu.com (“Ddu”) participated in the exhibition and gaining an outstanding reputation from a number of exhibitors because of its business concept and service pattern.
The 5th Myanmar International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) will be held in Myanmar's capital, Yangon, during July 5 - 7, 2017. Drugdu.com(“Ddu”), the first global pharmaceuticals and medical devices B2B online platform, will be participating in the exhibition to showcase the new method of cross-border medical trade from China.
CPhI China 2017 was held at the Shanghai New International Expo Center from June 20 to 22. As the leading global pharmaceuticals and medical devices industry platform, Ddu presented a wide range of services which connect the traditional medical industry with the Internet including one-stop service solutions, buying offer sharing of global exhibitions, credit verification and so forth.
INTERPHEX JAPAN will be held in Big Sight, Tokyo from June 28th - 30th. As the leading global pharmaceuticals and medical devices B2B online platform, Ddu will attend the fair with products from high priority members.
CPhI China 2017 will be held from 20th June to 22nd June 2017 at the Shanghai New International Expo Center (SNIEC) in Shanghai, China. Ddu, the leading global pharmaceuticals and medical devices B2B platform , will attend the exhibition with products from high-priority members and launch synchronization services of buy offers and agency service.
Both the Shanghai CMEF 2017 and Sao Paulo Hospitalar 2017 came to an end recently. As a global leading pharmaceutical and medical device B2B online platform, Ddu attended the two fairs, showcasing products of high priority users.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.